These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30691475)

  • 61. The prognostic significance of Src and p-Src expression in patients with osteosarcoma.
    Hu C; Deng Z; Zhang Y; Yan L; Cai L; Lei J; Xie Y
    Med Sci Monit; 2015 Feb; 21():638-45. PubMed ID: 25725252
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
    Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The expression and function of miRNA-451 in osteosarcoma.
    Yuan J; Lang J; Liu C; Zhou K; Chen L; Liu Y
    Med Oncol; 2015 Jan; 32(1):324. PubMed ID: 25471786
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis.
    Abd El-Rehim DM; Osman NA
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):1-9. PubMed ID: 25481287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray.
    Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
    Anticancer Res; 2014 Aug; 34(8):3881-9. PubMed ID: 25075009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nrf2 expression is associated with poor outcome in osteosarcoma.
    Park JY; Kim YW; Park YK
    Pathology; 2012 Dec; 44(7):617-21. PubMed ID: 23172081
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
    Xie Y; Huang J; Wu M; Zhou Y
    J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
    Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
    Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The expression of CRM1 is associated with prognosis in human osteosarcoma.
    Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
    Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
    Li GL; Wu YX; Li YM; Li J
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.
    Deng Z; Niu G; Cai L; Wei R; Zhao X
    Biomed Res Int; 2013; 2013():496193. PubMed ID: 23971040
    [TBL] [Abstract][Full Text] [Related]  

  • 77. cPLA
    Pang X; Yin P; Han J; Wang Z; Zheng F; Chen X
    Pathol Res Pract; 2019 Jun; 215(6):152398. PubMed ID: 31003849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
    Liu ZX; Hong L; Fang SQ; Tan GH; Huang PG; Zeng Z; Xia X; Wang XX
    Tumour Biol; 2016 Nov; 37(11):14923-14928. PubMed ID: 27644251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Growth patterns of osteosarcoma predict patient survival.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.